Trejo F, De la Vega M T, Arias-Montaño J A
Departamento de Fisiología, Biofísica y Neurociencias, Centro de Investigación y de Estudios Avanzados, México, D.F., Mexico.
Eur J Pharmacol. 1996 Dec 27;318(1):175-84. doi: 10.1016/s0014-2999(96)00781-9.
In cross-chopped slices from rat thalamus and in the presence of 10 mM LiCl, noradrenaline stimulated the accumulation of [3H]inositol phosphates with [3H]inositol monophosphates ([3H]IP1) being the major product detected (86 +/- 2% of total [3H]inositol phosphates). Noradrenaline-induced [3H]IP1 accumulation was concentration-dependent and yielded and EC50 of 4.6 +/- 0.2 microM, maximum effect of 272 +/- 3% of basal formation and Hill coefficient (nH) of 1.6 +/- 0.1. The effect of 100 microM noradrenaline was inhibited by the alpha 1-adrenoceptor antagonists prazosin, (+)-niguldipine, 5-methylurapidil and WB-4101 (2-(2,6-dimethoxyphenoxyethyl) aminomethyl-1,4-benzodioxane). The inhibition curve for prazosin best fit to a single-site model whereas curves for (+)-niguldipine, 5-methylurapidil and WB-4101 best fit to a two-site model. The putative alpha 1D-adrenoceptor-selective antagonist BMY 7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8- azaspiro[4.5]decane-7,9-dione) showed low potency and efficacy to inhibit the response to noradrenaline. Pre-treatment of the slices with chloroethylclonidine (100 microM; 30 min) decreased by 64 +/- 4% the maximum response. Noradrenaline-induced [3H]IP1 accumulation was significantly reduced by Ca2+ removal (by 64 +/- 2%) and by the Ca(2+)-channel blockers Ni2+, Co2+ and nimodipine (inhibition of 56 +/- 6%, 54 +/- 5% and 41 +/- 5%, respectively). Taken together these results indicate that noradrenaline-induced inositol phosphate formation in thalamus slices is mainly mediated by the activation of both alpha 1B and alpha 1A subtypes of alpha 1-adrenoceptors.
在大鼠丘脑的交叉切片中,且存在10 mM 氯化锂的情况下,去甲肾上腺素刺激了[3H]肌醇磷酸的积累,其中[3H]肌醇一磷酸([3H]IP1)是检测到的主要产物(占总[3H]肌醇磷酸的86±2%)。去甲肾上腺素诱导的[3H]IP1积累呈浓度依赖性,其半数有效浓度(EC50)为4.6±0.2 μM,最大效应为基础生成量的272±3%,希尔系数(nH)为1.6±0.1。100 μM去甲肾上腺素的效应被α1肾上腺素能受体拮抗剂哌唑嗪、(+)-尼群地平、5-甲基尿嘧啶和WB-4101(2-(2,6-二甲氧基苯氧基乙基)氨基甲基-1,4-苯并二恶烷)抑制。哌唑嗪的抑制曲线最符合单一位点模型,而(+)-尼群地平、5-甲基尿嘧啶和WB-4101的曲线最符合双位点模型。假定的α1D肾上腺素能受体选择性拮抗剂BMY 7378(8-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-8-氮杂螺[4.5]癸烷-7,9-二酮)对抑制去甲肾上腺素反应的效力和效能较低。用氯乙可乐定(100 μM;30分钟)预处理切片可使最大反应降低64±4%。去除Ca2+(降低64±2%)以及Ca2+通道阻滞剂Ni2+、Co2+和尼莫地平(分别抑制56±6%、54±5%和41±5%)可显著降低去甲肾上腺素诱导的[3H]IP1积累。综上所述,这些结果表明,去甲肾上腺素诱导丘脑切片中肌醇磷酸形成主要是由α1肾上腺素能受体的α1B和α1A亚型的激活介导的。